Ocugen, Inc.
OCGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001372299
In the last 90 days, Ocugen, Inc. insiders filed 0 open-market purchases and 1 sale; 147 institutions reported holding it in 13F filings for Q2 2026, worth $222.1M in total; no superinvestor holds it.
Holders of 5% or more of OCGN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ocugen, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Janus Henderson Group PLC | 13G | 6.00%20.0M shares | New | Dec 8, 20251 filing | Dec 8, 2025 | SEC |
| Millennium Management LLC | 13G | 5.20%17.1M shares | New | Apr 14, 20261 filing | Apr 14, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
7 Schedule 13D and 13G filings on Ocugen, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 14, 20266:38 PM ET | Millennium Management LLCand 2 others | 13G | 5.20%17.1M shares | New | Apr 9, 2026 | SEC |
| Mar 27, 202611:04 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −5.27 ppfrom 5.27%Below 5% | Mar 13, 2026 | SEC |
| Jan 30, 20262:16 PM ET | Vanguard Group Inc | 13G | 5.27%16.5M shares | +0.40 ppfrom 4.87% | Dec 31, 2025 | SEC |
| Dec 8, 202511:45 AM ET | Janus Henderson Group PLC | 13G | 6.00%20.0M shares | New | Nov 28, 2025 | SEC |
| Oct 31, 202511:03 AM ET | Vanguard Group Inc | 13G/A | 4.87%15.2M shares | –Below 5% | Sep 30, 2025 | SEC |
| Jul 17, 20257:54 PM ET | BlackRock, Inc. | 13G/A | 1.90%5.52M shares | –Below 5% | Jun 30, 2025 | SEC |
| Feb 5, 20257:30 AM ET | State Street Corp | 13G | 2.00%5.87M shares | NewBelow 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Ocugen, Inc. shares.
No Form 144 notices for Ocugen, Inc. are on file.